Home
Live Updates
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results : comparemela.com
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results
Preliminary unaudited total net revenue for the fourth quarter and full year 2023 of approximately $45 million and $176 million
Preliminary unaudited net product revenue for the fourth quarter and...
Related Keywords
Maryland ,
United States ,
United Kingdom ,
Canada ,
Italy ,
Rockville ,
Spain ,
Japan ,
Japanese ,
Canadian ,
Peter Greenleaf ,
Nasdaq ,
Exchange Commission Electronic Document Gathering ,
Aurinia Pharmaceuticals Inc ,
Otsuka Pharmaceuticals Co Ltd ,
Aurinia Pharmaceuticals ,
Executive Leadership ,
Investigational New Drug ,
Fourth Quarter ,
Annual Report ,
Canadian Securities Administrator System ,
Electronic Document Analysis ,
Exchange Commission ,
Electronic Document Gathering ,
Retrieval System ,
Markets ,
comparemela.com © 2020. All Rights Reserved.